This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Medical University of Vienna. Active years: 2023.
Company Filing History:
1 out of 1,328 
1 out of 33 
Years Active: 2023
Title: The Innovative Contributions of Stephen Reece
Introduction
Stephen Reece is a notable inventor based in Brentwood, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of latent tuberculosis infections. His innovative approach has the potential to improve the accuracy and efficiency of diagnosing this condition.
Latest Patents
Stephen Reece holds a patent for "Methods for the detection of a latent tuberculosis infection." This invention relates to a method for the in vitro detection of a latent tuberculosis infection (LTBI) in a subject. The method involves determining at least one nucleotide sequence and/or at least one polypeptide of Mycobacterium tuberculosis (Mtb) in a blood cell population of the subject. The presence of these sequences or polypeptides is indicative of a latent tuberculosis infection. The blood cell population is specifically enriched for hematopoietic stem cells. Additionally, the invention includes a pharmaceutical composition for treating LTBI and kits for carrying out the methods.
Career Highlights
Throughout his career, Stephen Reece has worked with esteemed organizations such as the Max Planck Society and the Medical University of Vienna. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Stephen has collaborated with notable individuals, including Julia Tornack and Stefan H. E. Kaufmann. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Stephen Reece's innovative work in the detection of latent tuberculosis infections showcases his commitment to advancing medical diagnostics. His contributions have the potential to significantly impact public health and improve patient outcomes.